Literature DB >> 18425764

Production of a heterozygous mutant cell line by homologous recombination (single knockout).

Richard Mortensen1.   

Abstract

Gene targeting by homologous recombination is a powerful and widely used technique for introduction of specific gene mutations (frequently a gene inactivation) in transgenic animals. The basic method detailed in this unit uses sequences homologous to the endogenous gene flanking the mutation. While methods using bacterial artificial chromosomes (BACs) and recombineering may be used, in most cases simpler bacterial plasmid clones with several kb of homology are sufficient. This protocol details the strategic factors in designing the constructs for selection and screening for homologous recombination. (c) 2008 by John Wiley & Sons, Inc.

Mesh:

Year:  2008        PMID: 18425764     DOI: 10.1002/0471142727.mb2305s82

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  3 in total

1.  No evidence of non-homologous insertions in mouse model of MDD created by replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-01       Impact factor: 3.568

2.  Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals.

Authors:  Seshu Tummala; Michael Titus; Lee Wilson; Chunhua Wang; Carlo Ciatto; Greg Thill; Donald Foster; Chen Li; Zoltan Szabo; Andras Guttman; Brian Bettencourt; Muthuswamy Jayaraman; Jack Deroot; David Kocisko; Stuart Pollard; Klaus Charisse; Satya Kuchimanchi; Greg Hinkle; Stuart Milstein; Rachel Meyers; Shiaw-Lin Wu; Barry L Karger; Anthony Rossomando
Journal:  Biotechnol Prog       Date:  2013-02-13

3.  MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation.

Authors:  Lars Bräutigam; Jie Zhang; Kristian Dreij; Linda Spahiu; Arne Holmgren; Hiroshi Abe; Kenneth D Tew; Danyelle M Townsend; Michael J Kelner; Ralf Morgenstern; Katarina Johansson
Journal:  Redox Biol       Date:  2018-04-16       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.